Lexicon Pharmaceuticals LXRX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's operating lease liabilities (total)?
- Lexicon Pharmaceuticals (LXRX) reported operating lease liabilities (total) of $8.02M in Q1 2026.
- How has Lexicon Pharmaceuticals's operating lease liabilities (total) changed year-over-year?
- Lexicon Pharmaceuticals's operating lease liabilities (total) increased by 44.2% year-over-year, from $5.56M to $8.02M.
- What is the long-term trend for Lexicon Pharmaceuticals's operating lease liabilities (total)?
- Over 2 years (2023 to 2025), Lexicon Pharmaceuticals's operating lease liabilities (total) has grown at a 12.1% compound annual growth rate (CAGR), from $6.56M to $8.23M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.